Clinical trial

To Study the Safety and Effectiveness of a Granisetron Patch to Treat…

NCT00273468 · Kyowa Kirin Co., Ltd., Industry · Completed

Key facts

NCT number NCT00273468
Title To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)
Official title A Randomised, Active Control, Double-blind, Double-dummy, Parallel-group, Multi-national Study to Assess the Efficacy, Tolerability and Safety of the Granisetron Transdermal Delivery System in Chemotherapy-induced Nausea and Vomiting (CINV) Associated With the Administration of Moderately or Highly…
Lead sponsor Kyowa Kirin Co., Ltd., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Chemotherapy-induced Nausea and Vomiting
Intervention type Drug
Interventions Granisetron
Enrollment 630
Start date Jan 1, 2006
Completion Oct 1, 2006
First posted Jan 9, 2006
Last update posted Jun 17, 2024

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies